Skip to content

IMMULITE® 2000 Systems OV OM-MA (CA125) 10380972Recalls & reported problems

Siemens Healthcare Diagnostics Products Ltd · CA 125 - IMMULITE - RGT - 200 Tests · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00630414961798), received between Aug 9, 2022 and Mar 24, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “High Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results1
  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 24, 2026High Test Results

    THE CUSTOMER REPORTED THE OBSERVATION OF A DISCORDANT ELEVATED OM-MA (OV) PATIENT RESULT WHEN USING KIT LOT 321 ON AN IMMULITE 2000 XPI INSTRUMENT. THE INITIAL RESULT WAS REPORTED TO AND QUESTIONED BY THE PHYSICIAN(S). THE SAMPLE WAS REPEATED ON THE INITIAL INSTRUMENT, AND THE REPEAT RESULT WAS LOWER, AND REPORTED AS THE CORRECT RESULT, TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24681026 ↗
  • MalfunctionAug 9, 2022Low Test Results; Low Test Results

    THE CUSTOMER OBSERVED DEPRESSED IMMULITE 2000 XPI OM-MA (CA125) DILUTED RESULTS FOR A PATIENT SAMPLE COMPARED TO REPEAT DILUTED RESULTS USING THE SAME INSTRUMENT. THE INITIAL RESULT READ ABOVE ASSAY MEASURING RANGE (500 U/ML) AND ONBOARD DILUTIONS WERE PERFORMED THREE TIMES WITH THE SAME SAMPLE. DISCORDANT LOW RESULTS WERE OBSERVED WITH THE FIRST SET OF DILUTED SAMPLE RESULTS. THE INITIAL DILUTED RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT IMMULITE 2000 XPI OM-MA (CA125) RESULTS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15195580 ↗

Other TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125) devices

All TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page